News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
Intercell's strategic Flu partner Novartis to include IC31® in further clinical trials
29-Feb-2008 - Intercell AG announced the completion of Phase I clinical trials of the companys adjuvant IC31® in combination with the seasonal, trivalent influenza vaccine Agrippal® from Novartis. In this randomized, controlled Phase I trial, 72 individuals received one shot of either Agrippal®, or Agrippal® ...
28-Feb-2008 - NPS Pharmaceuticals, Inc. announced that Dr. Tony Coles will be stepping down from his positions as president, chief executive officer and a director effective March 17, 2008 to become president, chief executive officer and a director of Onyx Pharmaceuticals, Inc. He will be succeeded by NPS ...
28-Feb-2008 - Circassia Ltd announced that it has initiated a phase II clinical study with its anti-allergy technology, ToleroMune. Circassia is conducting the study in the field of cat-dander allergy, and aims to complete the trial in the coming months. This clinical study builds on the results of a previous ...
28-Feb-2008 - Glide Pharma has signed an agreement with a pharmaceutical company to evaluate its proprietary Glide SDI(tm) - Solid Dose Injector - technology for the delivery of a branded peptide product. This is Glide Pharma's third deal involving a biological product, with further agreements close to ...
27-Feb-2008 - Welichem Biotech Inc. announced that Health Canada approved the Company's Clinical Trial Application (CTA) to begin a Phase IIa Clinical Trial of its anti-inflammatory drug candidate, WBI-1001, on atopic dermatitis (a type of eczema). The Company will initiate its Phase IIa Clinical Trial of ...
27-Feb-2008 - Oncothyreon Inc. announced the presentation of data demonstrating the effectiveness of PX-478 in a preclinical model of human lung cancer at the 8th Annual Targeted Therapies of the Treatment of Lung Cancer meeting of the International Association for the Study of Lung Cancer in Santa Monica, ...
27-Feb-2008 - Acambis plc announced that it has initiated pre-clinical trials with a herpes vaccine, licensed from Harvard University through its Office of Technology Development, with a view to submitting an Investigational New Drug (IND) application in 2009. The dl5-29 HSV-2 vaccine was developed by a ...
Collaboration Targets a Non-Dopaminergic Approach to Treating Parkinson's Disease
27-Feb-2008 - Addex Pharmaceuticals announced that the first preclinical milestone has been achieved in a recently announced exclusive collaboration and license agreement with Merck & Co., Inc. (through its affiliate Merck Sharp & Dohme Research Ltd). The collaboration is focused on developing an emerging ...
26-Feb-2008 - Nexia Biotechnologies Ltd. announced that it has acquired ownership of an aggregate of 19,765,032 common shares of Inflazyme Pharmaceuticals Ltd. representing 15.1% of the issued and outstanding common shares of Inflazyme. Nexia acquired ownership of 19,765,032 Inflazyme shares at a price of ...
26-Feb-2008 - In light of Neurochem Inc.'s new strategic direction, the Company announced the departure, effective February 21, 2008, of two members of its senior management team, Dr. Andreas Orfanos, MBB. Ch, MBA, Executive Vice President, Strategic Planning and Scientific Affairs, and Ms. Christine Lennon, ...
© 1997-2024 LUMITOS AG, All rights reserved